Gut Dysbiosis Associated With Hepatitis C Virus Infection.

Background Little is known about the effect of hepatitis C virus (HCV) infection on gut microbiota and the relationship between alteration of gut microbiota and chronic hepatitis C (CHC) progression. We performed a comparative study of gut microbiota composition between CHC patients and healthy indi...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Infectious Diseases Vol. 67; no. 6; pp. 869 - 878
Autores principales: Inoue, Takako, Nakayama, Jiro, Moriya, Kei, Kawaratani, Hideto, Momoda, Rie, Ito, Kiyoaki, Iio, Etsuko, Nojiri, Shunsuke, Fujiwara, Kei, Yoneda, Masashi
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA 9/15/2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=131509934&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 131509934
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10584838
        46X
      jtl: Clinical Infectious Diseases
      issn: 10584838
      maglogo: N
    pubinfo:
      dt: 9/15/2018
      vid: 67
      iid: 6
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        131509934
        131509934
        131509934
        10.1093/cid/ciy205
        131509934
      ppf: 869
      ppct: 9
      formats:
      tig:
        atl: Gut Dysbiosis Associated With Hepatitis C Virus Infection.
      aug:
        au:
          Inoue, Takako
          Nakayama, Jiro
          Moriya, Kei
          Kawaratani, Hideto
          Momoda, Rie
          Ito, Kiyoaki
          Iio, Etsuko
          Nojiri, Shunsuke
          Fujiwara, Kei
          Yoneda, Masashi
        affil: Department of Clinical Laboratory Medicine, Nagoya City University Hospital
      sug:
        subj:
          Gut Microbiota Pathology
          Hepatitis C, Chronic Microbiology
          Disease Progression
          Human
          Comparative Studies
          Feces Analysis
          Sequence Analysis Methods
          RNA Analysis
          Hepatitis C, Chronic Diagnosis
          Alanine Aminotransferase Blood
          Liver Cirrhosis Familial and Genetic
          Carcinoma, Hepatocellular
          Streptococcus
          Lactobacillus
          Genome
          Urease
          Bacteroides
          Enterobacteriaceae
          Viridans Streptococci
          Metabolic Diseases
          Liver Cirrhosis Etiology
          Hepatitis C, Chronic Complications
      ab: Background Little is known about the effect of hepatitis C virus (HCV) infection on gut microbiota and the relationship between alteration of gut microbiota and chronic hepatitis C (CHC) progression. We performed a comparative study of gut microbiota composition between CHC patients and healthy individuals. Methods Fecal samples from 166 CHC patients were compared with those from 23 healthy individuals; the gut microbiota community was analyzed using 16S ribosomal RNA gene sequencing. CHC patients were diagnosed with persistently normal serum alanine aminotransferase without evidence of liver cirrhosis (LC) (PNALT, n = 18), chronic hepatitis (CH, n = 84), LC (n = 40), and hepatocellular carcinoma in LC (n = 24). Results Compared with healthy individuals, bacterial diversity was lower in persons with HCV infection, with a decrease in the order Clostridiales and an increase in Streptococcus and Lactobacillus. Microbiota dysbiosis already appeared in the PNALT stage with the transient increase in Bacteroides and Enterobacteriaceae. Predicted metagenomics of microbial communities showed an increase in the urease gene mainly encoded by viridans streptococci during CHC progression, consistent with a significantly higher fecal pH in CH and LC patients than in healthy individuals or those in the PNALT stage. Conclusions HCV infection is associated with gut dysbiosis, even in patients with mild liver disease. Additionally, overgrowth of viridans streptococci can account for hyperammonemia in CH and LC. Further studies would help to propose a novel treatment strategy because the gut microbiome can be therapeutically altered, potentially reducing the complications of chronic liver disease.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N